ATE357530T1 - Verfahren zum ändern der expression von hyphen- spezifischen genen - Google Patents

Verfahren zum ändern der expression von hyphen- spezifischen genen

Info

Publication number
ATE357530T1
ATE357530T1 AT00982261T AT00982261T ATE357530T1 AT E357530 T1 ATE357530 T1 AT E357530T1 AT 00982261 T AT00982261 T AT 00982261T AT 00982261 T AT00982261 T AT 00982261T AT E357530 T1 ATE357530 T1 AT E357530T1
Authority
AT
Austria
Prior art keywords
expression
hyphal
altering
specific genes
infection
Prior art date
Application number
AT00982261T
Other languages
English (en)
Inventor
Paula Sundstrom
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dartmouth College filed Critical Dartmouth College
Application granted granted Critical
Publication of ATE357530T1 publication Critical patent/ATE357530T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00982261T 1999-11-29 2000-11-29 Verfahren zum ändern der expression von hyphen- spezifischen genen ATE357530T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16767299P 1999-11-29 1999-11-29

Publications (1)

Publication Number Publication Date
ATE357530T1 true ATE357530T1 (de) 2007-04-15

Family

ID=22608310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00982261T ATE357530T1 (de) 1999-11-29 2000-11-29 Verfahren zum ändern der expression von hyphen- spezifischen genen

Country Status (6)

Country Link
US (1) US20020142468A1 (de)
EP (1) EP1235918B1 (de)
AT (1) ATE357530T1 (de)
AU (1) AU1931601A (de)
DE (1) DE60034058D1 (de)
WO (1) WO2001038550A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022989A2 (en) * 2001-09-10 2003-03-20 University Of Iowa Research Foundation Therapeutic agents that inhibit the tup1 pathway
WO2006063117A2 (en) * 2004-12-07 2006-06-15 California Institute Of Technology Identifying cis-regulatory modules by comparative genomics
JP2008535513A (ja) * 2005-04-14 2008-09-04 ナショナル・ユニバーシティ・オブ・アイルランド・ガルウェイ Ｃ．ａｌｂｉｃａｎｓの検出方法
GB201306588D0 (en) 2013-04-11 2013-05-29 King S College London Peptides and Binding Partners Therefor
US10106790B2 (en) * 2014-09-22 2018-10-23 Trustees Of Dartmouth College Intergenic RNAS and methods for modulating gene expression and pathogenesis in candida
AU2015345979A1 (en) * 2014-11-10 2017-06-01 Murdoch Childrens Research Institute Vectors and methods for targeted integration in loci comprising constitutively expressed genes

Also Published As

Publication number Publication date
US20020142468A1 (en) 2002-10-03
WO2001038550A2 (en) 2001-05-31
AU1931601A (en) 2001-06-04
DE60034058D1 (de) 2007-05-03
EP1235918A2 (de) 2002-09-04
WO2001038550A3 (en) 2002-01-31
EP1235918B1 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
DE60330841D1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
Slany et al. Formation of Staphylococcus aureus biofilm in the presence of sublethal concentrations of disinfectants studied via a transcriptomic analysis using transcriptome sequencing (RNA-seq)
ATE464889T1 (de) Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
ATE320500T1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
ATE524195T1 (de) Monoklonale antikörper gegen das clfa-protein und verfahren zur verwendung bei der behandlung bzw. pr vention von infektionen
ATE532877T1 (de) Nukleinsäuremoleküle zum nachweis von bakterien und phylogenetischen einheiten von bakterien
DE60219793D1 (de) Methode zur behandlung von zytokinvermittelten erkrankungen
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
EP1471926B8 (de) Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
ATE357530T1 (de) Verfahren zum ändern der expression von hyphen- spezifischen genen
WO2004010925A3 (en) Mammalian genes involved in viral infection and tumor suppression
EA202192454A1 (ru) Новый ингибитор mek для лечения вирусных и бактериальных инфекций
WO2003106476A8 (en) INHIBITION OF ENTEROCOCCAL INFECTION AND CYTOLYSIN ACTIVITY INDUCED BY NUCLEIC ACIDS
ATE465261T1 (de) Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken
DE602004031435D1 (de) Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus
AU2180501A (en) Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide
ATE394503T1 (de) Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können
ATE331799T1 (de) Verfahren zur inhibierung der transkription von genen
DK1177316T3 (da) Polynukleotidprober til sporing og kvantisering af actinomycetes
ATE467422T1 (de) Behandlung von aspergillus-infektionen mit thymosin alpha 1
WO2020245783A3 (en) Method and system for identification of target sites in protein coding regions for combating pathogens
CY1108781T1 (el) Εμβολιο ψαριων
FR2760749B1 (fr) Oligonucleotides derives des genes vts de bacteries e. coli productrices de verotoxines, et leurs utilisations
ATE219368T1 (de) Verwendung von prostanderivaten und deren kombination mit antibiotika in der behandlung bakterieller infektionen
ATE443257T1 (de) Verfahren zur identifizierung von tff2 regulierenden agentien

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties